These marine compounds can regulate redox-sensitive signaling pathways such as Nrf2/ARE activation and NF-κB inhibition, which make these bioactive agents’ effective modulators in controlling not only primary metabolic defects in diabetes, but also in the prevention and treatment of secondary complications. The gene discussed is NFKB1; the disease is diabetes mellitus.